PA Constans - Minnesota Emu FDA Warning (2018)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on February 23, 2018
Executive Summary
The FDA issued a warning letter to PA Constans - Minnesota Emu on February 23, 2018 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Minneapolis District Office.
Detailed Analysis
False Claims and Regulatory Violations
“Australia’s Aborigines have been using emu oil for centuries to treat pain, burns and bug bites & stings.”
I started my radiation treatment in October…My burns were very minimal and I had no pigment changes at all. My oncologist agreed that this was due to me being faithful with moisturizing with Emu Oil.”
Potential Health Risks
(testimonial) “I have [dry itchy skin]* on my midsection and legs. Emu Oil really does help alleviate the redness and itching. I would rather use a natural product than a pharmaceutical.” *redacted as per FDA regulation.”
(testimonial) “I had toenail fungus for decades. Used medically prescribed Rx and many over the counter products. Nothing worked. Starting using Omega Magic and after 9 weeks – the old nail sluffed off and a healthy new nail was exposed.”
Regulatory Context
This warning letter is part of the FDA's enforcement of federal regulations.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with PA Constans - Minnesota Emu?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are PA Constans - Minnesota Emu products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used PA Constans - Minnesota Emu products?
- If you have used products from PA Constans - Minnesota Emu and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter